Search
for

    Sort by

    Research

    990-1000 / 1000+ results
      Table 2

      research Table_2.docx

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.
      Table 1

      research Table_1.docx

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

      research SnapshotDx Quiz: January 2021

      December 2020 in “˜The œjournal of investigative dermatology/Journal of investigative dermatology”
      Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

      research Subject Index

      February 2009 in “Journal of the American Academy of Dermatology”

      research Subject Index

      November 2008 in “Journal of the American Academy of Dermatology”